Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in stable type 2 diabetes mellitus
NCT01585051Phase 3Completed
- Sponsor
- Kantonsspital Baselland
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcifediol in type 2 diabetes mellitus (T2DM), sponsored by Kantonsspital Baselland. Primary endpoints: Glycated Hemoglobin at 6 months and 24 hour mean blood pressure at 6 months. Started Jan 2009; status: completed.
02
Drugs
calcifediol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01585051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585051.